Hyderabad-based Natco Pharma has sought permission from drug major Pfizer to sell discounted copies of its HIV drug. In an interview with CNBC-TV18, Bhaskar Narayana, Finance Director & CFO, Natco Pharma threw light on the development and spoke on the company's business plans going forward.
first published: Jan 10, 2011 03:54 pm
A collection of the most-viewed Moneycontrol videos.
TCS Q2 Earnings Live: Margin, Revenue Beat Street Estimates
Live: Nifty reclaims 25,100 ahead of TCS Q2 results; pharma, metals shine | Closing Bell
Canara Robeco AMC's Rs 1326 Cr IPO Kicks Off | Management Shares Growth Plans| IPO Watch Live
Live: Can Nifty hold above 25,000 as TCS begins Q2 results | Opening Bell
